Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tschanz, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tschanz, J. T.
Related Collections
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
Right arrow MCI (mild cognitive impairment)
NEUROLOGY 2006;67:229-234
© 2006 American Academy of Neurology

Conversion to dementia from mild cognitive disorder

The Cache County Study

J. T. Tschanz, PhD, K. A. Welsh-Bohmer, PhD, C. G. Lyketsos, MD, MHS, C. Corcoran, PhD, R. C. Green, MD, MPH, K. Hayden, PhD, M. C. Norton, PhD, P. P. Zandi, PhD, L. Toone, MS, N. A. West, MS, J.C.S. Breitner, MD, MPH and the Cache County Investigators*

From the Department of Psychology (J.T.T., M.C.N.), Center for Epidemiologic Studies (J.T.T., C.C., M.C.N., L.T.), Department of Mathematics and Statistics (C.C.), and Department of Family, Consumer and Human Development (M.C.N.), Utah State University, Logan; Department of Psychiatry and Behavioral Sciences (K.A.W.-B.) and Center for the Study of Aging and Human Development (K.A.W.-B., K.H.), Duke University Medical Center, Durham, NC; Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, School of Medicine (C.G.L.), and Department of Mental Health, The Johns Hopkins Bloomberg School of Public Health (P.P.Z., C.G.L.), The Johns Hopkins University, Baltimore, MD; Departments of Neurology, Medicine (Genetics) and Epidemiology (R.C.G.), Boston University Schools of Medicine and Public Health, MA; Department of Epidemiology (N.A.W.), School of Public Health, University of Michigan, Ann Arbor; and VA Puget Sound Health Care System, and Department of Psychiatry and Behavioral Sciences (J.C.S.B.), University of Washington School of Medicine, Seattle.

Address correspondence and reprint requests to Dr. JoAnn T. Tschanz, Associate Professor, Department of Psychology, 4440 Old Main Hill, Logan, UT 84322-4440; e-mail: joannt{at}cc.usu.edu.

Objective: To examine 3-year rates of conversion to dementia, and risk factors for such conversion, in a population-based sample with diverse types of cognitive impairment.

Methods: All elderly (aged 65 or older) residents of Cache County, UT, were invited to undergo two waves of dementia screening and assessment. Three-year follow-up data were available for 120 participants who had some form of mild cognitive impairment at baseline. Of these, 51 had been classified at baseline with prodromal Alzheimer disease (proAD), and 69 with other cognitive syndromes (CS).

Results: Three-year rates of conversion to dementia were 46% among those with cognitive impairment at baseline. By comparison, 3.3% without impairment converted to dementia in the interval. Among converters, AD was the most common type of dementia. In individuals with at least one APOE {varepsilon}4 allele, those with proAD or CS exhibited a 22- to 25-fold higher risk of dementia than cognitively unimpaired individuals (vs 5- to 10-fold higher risk in those without {varepsilon}4).

Conclusions: Individuals with all types of mild cognitive impairment have an elevated risk of dementia over 3 years, more so in those with an APOE {varepsilon}4 allele. These results suggest value in dementia surveillance for broad groups of cognitively impaired individuals beyond any specific category, and utility of APOE genotyping as a prognostic method.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the July 25 issue to find the title link for this article.

*Other Cache County Study Investigators are listed in the appendix.

Supported by R01-AG11380 (Cache County Study of Memory in Aging) and by R01-AG21136 (Cache Dementia Progression Study).

Presented in preliminary form at the 8th International Conference on Alzheimer’s Disease and Related Disorders and at the 31st Annual Meeting of the International Neuropsychological Society.

Disclosure: The authors report no conflicts of interest.

Received August 29, 2005. Accepted in final form March 21, 2006.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
K. A. Swanson and R. M. Carnahan
Dementia and Comorbidities: An Overview of Diagnosis and Management
Journal of Pharmacy Practice, August 1, 2007; 20(4): 296 - 317.
[Abstract] [PDF]


Home page
NeurologyHome page
ADAPT Research Group
Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial
Neurology, May 22, 2007; 68(21): 1800 - 1808.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Hussain, K . Peres, V . Chrysostome, C . Fabrigoule, J .-M. Orgogozo, J .-F. Dartigues, and P . Barberger-Gateau
RESTRICTION IN COMPLEX ACTIVITIES OF DAILY LIVING IN MCI: IMPACT ON OUTCOME
Neurology, May 1, 2007; 68(18): 1544 - 1545.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
P. B. Rosenberg, D. Johnston, and C. G. Lyketsos
A Clinical Approach to Mild Cognitive Impairment
Am J Psychiatry, November 1, 2006; 163(11): 1884 - 1890.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.